PERNIOLA, GIORGIA
 Distribuzione geografica
Continente #
NA - Nord America 5.694
EU - Europa 2.808
AS - Asia 1.289
AF - Africa 85
SA - Sud America 51
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.932
Nazione #
US - Stati Uniti d'America 5.609
IT - Italia 1.273
SG - Singapore 592
DE - Germania 332
IN - India 316
SE - Svezia 310
CN - Cina 217
FI - Finlandia 207
RU - Federazione Russa 207
UA - Ucraina 81
BG - Bulgaria 66
TG - Togo 62
GB - Regno Unito 53
BE - Belgio 51
CA - Canada 47
IE - Irlanda 45
MX - Messico 36
ID - Indonesia 35
FR - Francia 34
NL - Olanda 24
AT - Austria 22
BR - Brasile 20
RO - Romania 19
AR - Argentina 14
ES - Italia 14
IR - Iran 14
TR - Turchia 14
IL - Israele 13
PH - Filippine 13
PL - Polonia 13
EG - Egitto 12
JP - Giappone 11
HK - Hong Kong 10
PT - Portogallo 10
TW - Taiwan 10
CH - Svizzera 9
GR - Grecia 7
KR - Corea 7
MY - Malesia 7
DK - Danimarca 6
CO - Colombia 5
MK - Macedonia 5
CL - Cile 4
EC - Ecuador 4
LT - Lituania 4
NO - Norvegia 4
PE - Perù 4
AU - Australia 3
HU - Ungheria 3
IQ - Iraq 3
KG - Kirghizistan 3
LK - Sri Lanka 3
PK - Pakistan 3
VN - Vietnam 3
YE - Yemen 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
BJ - Benin 2
CZ - Repubblica Ceca 2
MA - Marocco 2
RS - Serbia 2
SC - Seychelles 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BZ - Belize 1
DZ - Algeria 1
EU - Europa 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
MV - Maldive 1
NZ - Nuova Zelanda 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 9.932
Città #
Fairfield 956
Rome 532
Ashburn 515
Singapore 422
Chandler 404
Woodbridge 388
Seattle 344
Houston 300
Wilmington 298
Cambridge 254
Ann Arbor 197
Santa Clara 182
Princeton 175
Beijing 144
San Paolo di Civitate 140
Helsinki 107
Plano 107
Lawrence 94
Millbury 92
San Diego 81
Bremen 74
Boston 72
Dearborn 71
Sofia 66
Lomé 62
Brussels 49
Milan 49
Andover 43
Dublin 42
Jakarta 35
Moscow 31
New York 29
Norwalk 29
Toronto 28
Des Moines 26
Los Angeles 26
Jacksonville 20
Falkenstein 19
Vienna 16
Council Bluffs 15
Mannheim 15
Naples 15
Redwood City 15
Yubileyny 14
Florence 13
Frankfurt am Main 13
Turin 13
Bologna 12
Federal 12
London 12
Nuremberg 12
Hyderabad 11
Quezon City 10
Falls Church 9
Hefei 9
La Jolla 9
Boardman 8
Kaohsiung City 8
Mexico City 8
Mit Ghamr 8
North York 8
Paris 8
Tokyo 8
Fremont 7
Hong Kong 7
Kunming 7
Parma 7
San Francisco 7
Brescia 6
Bühl 6
Changsha 6
Gainesville 6
Istanbul 6
Lappeenranta 6
Mumbai 6
Palermo 6
San Mateo 6
Barcelona 5
Catania 5
Fort Worth 5
Indiana 5
La Paz 5
Marino 5
Munich 5
Pune 5
Sacramento 5
Arezzo 4
Arzignano 4
Bern 4
Nanjing 4
Oslo 4
Ottawa 4
Pomigliano D'arco 4
Porto 4
Quito 4
Secaucus 4
São Paulo 4
Torino 4
Vejle 4
Wuhan 4
Totale 6.974
Nome #
HPV vaccination after primary treatment of HPV-related disease across different organ sites: a multidisciplinary comprehensive review and meta-analysis 152
The Efficacy of Fractional {CO}2 Laser in the Treatment of Genitourinary Syndrome of Menopause. A Large Prospective Observational Study 150
Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cells 113
Recurrent Buschke-Löwenstein Tumor Treated Using CO2 Laser Vaporization 110
Type B versus Type C Radical Hysterectomy After Neoadjuvant Chemotherapy in Locally Advanced Cervical Carcinoma: A Propensity-Matched Analysis 108
Severe pelvic organ prolapse treated by vaginal native tissue repair: long-term analysis of outcomes in 146 patients 105
Laparoscopically guided minilaparotomy: a minimally invasive approach for the treatment of gynaecologic diseases in morbidly obese patients 104
Update on fertility-sparing treatment in primary and recurrent endometrial cancer 97
A medical device containing purified bovine colostrum (Monurelle Biogel) in the treatment of vulvovaginal atrophy in postmenopausal women: Retrospective analysis of urinary symptoms, sexual function, and quality of life 96
Does Hormone Replacement Therapy Impact the Prognosis in Endometrial Cancer Survivors? A Systematic Review 96
MiR-200c-3p contrasts PD-L1 induction by combinatorial therapies and slows proliferation of epithelial ovarian cancer through downregulation of β-Catenin and c-Myc 94
Advances in anti-angiogenic agents for ovarian cancer treatment: the role of trebananib (AMG 386) 93
Neoadjuvant Chemotherapy Plus Fertility-Sparing Surgery in Locally Advanced Cervical Cancer: Case Report 92
Impact of hormone receptor status and Ki-67 expression on disease-free survival in patients affected by high-risk endometrial cancer 90
Ixabepilone for the treatment of endometrial cancer 90
Pfizer-BioNtech COVID-19 vaccine in gynecologic oncology patients. A prospective cohort study 89
Feasibility and safety of type C2 total extraperitoneal abdominal radical hysterectomy (TEARH) for locally advanced cervical cancer 88
Chemerin Regulates NK Cell Accumulation and Endothelial Cell Morphogenesis in the Decidua during Early Pregnancy 86
Age-Adjusted Charlson Comorbidity Index Predicts Survival in Endometrial Cancer Patients 85
A prospective phase II study of topotecan (Hycamtin®) and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer. 85
Benign schwannoma in supraclavicular region: a false-positive lymph node recurrence of breast cancer suspected by PET scan. 85
null 85
Splenic metastasis from cervical cancer: Case report and review of the literature 84
Protein–protein interaction network analysis applied to DNA copy number profiling suggests new perspectives on the aetiology of Mayer–Rokitansky–Küster–Hauser syndrome 83
The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients 82
Role of intraperitoneal chemotherapy in ovarian cancer in the platinum-taxane-based era: a meta-analysis 81
Altered expression of candidate genes in Mayer–Rokitansky–Küster–Hauser syndrome may influence vaginal keratinocytes biologya. A focus on Protein Kinase X 81
Adjuvant HPV Vaccination to Prevent Recurrent Cervical Dysplasia after Surgical Treatment: A Meta-Analysis 81
null 78
The EOLO (End-of-Life Ovarian Cancer) Study: Approach to ovarian cancer patients at the end of life 77
Role of chemotherapy in the management of vulvar carcinoma 76
Neoadjuvant chemotherapy followed by radical surgery in patients affected by vaginal carcinoma 76
Bulky lymph node resection in patients with recurrent epithelial ovarian cancer. impact of surgery 76
Sexual health and quality of life assessment among ovarian cancer patients during chemotherapy 75
Therapeutic Approaches to Vulvar Cancer. A Review of Literature 74
OC25.04: Three dimensional ultrasound to assess the chemotherapy response of locally advanced cervical cancer 74
Long-term experience of vaginal vault prolapse prevention at hysterectomy time by modified McCall culdoplasty or shull suspension. clinical, sexual and quality of life assessment after surgical intervention 74
Pelvic inflammatory disease. possible catches and correct management in young women 74
Autologous in vitro cultured vaginal tissue for vaginoplasty in women with Mayer-Von-Rokitansky-Küster-Hauser syndrome: anatomical and functional results 74
Uterine asymptomatic myomas: An overview from diagnosis to treatment 74
Retrospective analysis in 46 women with vulvovaginal atrophy treated with ospemifene for 12 weeks. improvement in overactive bladder symptoms 74
Conservative approaches in early stages of cervical cancer 73
null 72
Screening program in ovarian cancer: a logical step in clinical management? A meta-analysis 71
Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer 71
Intraperitoneal Chemotherapy: A Strategy for the Treatment of Refractory Ascites in Recurrent Endometrial Cancer Patients - Three Case Reports and Review of the Literature 71
Relationship between cervical excisional treatment for cervical intraepithelial neoplasia and obstetrical outcome 71
Calcineurin gamma catalytic subunit ppp3cc inhibition by mir-200c-3p affects apoptosis in epithelial ovarian cancer 71
Effect of neoadjuvant chemotherapy on primary treatment interval in patients with advanced ovarian cancer 70
Beyond the beyond: first case of 9 cytoreductive surgeries in a long-surviving ovarian cancer patient: case report 70
Accuracy of pelvic ultrasound in preoperative evaluation of uterine myomas: a prospective cohort study 70
The effect of surgery for endometrioma on ovarian reserve evaluated by antral follicle count: a systematic review and meta-analysis. 70
Recurrent mantle cell lymphoma in the uterine cervix: a case report 69
Neoadjuvant chemotherapy followed by radical surgery in patients affected by vaginal carcinoma 69
An Update of Laparoscopy in Cervical Cancer Staging: Is It a Useful Procedure? 68
CO2 Laser Treatment for Bartholin Gland Abscess: Ultrasound Evaluation of Risk Recurrence 67
Let's think twice before abandoning fibrillar oxidized regenerated cellulose 67
OTX015 epi‐drug exerts antitumor effects in ovarian cancer cells by blocking GNL3‐mediated radioresistance mechanisms: cellular, molecular and computational evidence 67
Dualistic classification of epithelial ovarian cancer: Surgical and survival outcomes in a large retrospective series 67
Hormonal replacement therapy and evaluation of intrauterine pathology in postmenopausal women: a ten-year study. 66
MODIFIED GLUTEAL FOLD ADVANCEMENT V-Y FLAP FOR VULVAR RECONSTRUCTION AFTER SURGERY FOR VULVAR MALIGNANCIES. 66
Complete remission after neoadjuvant chemotherapy of an advanced vulvar cancer patient: A case report 65
The role of 2d/3d ultrasound to assess the response to neoadjuvant chemotherapy in locally advanced cervical cancer 65
Hepatobiliary disease resection in patients with advanced epithelial ovarian cancer: prognostic role and optimal cytoreduction 65
Dose-Dense Neoadjuvant Chemotherapy plus Radical Surgery in Locally Advanced Cervical Cancer: A Phase II Study 64
Invasive vulvar carcinoma and the question of the surgical margin 63
OP29.03: Identification of parametria by 2D-3D ultrasound in patients with cervical cancer: new perspectives and future applications 63
Use of adjuvant therapy in patients with FIGO stage III endometrial carcinoma: a multicenter retrospective study. 62
Sonographic and clinical features of adenomyosis in women in "early" (18-35) and "advanced" (>35) reproductive ages 62
Persistent posttrachelectomy cervical stenosis treated with Petit-Le Four pessary in early cervical cancer patients: a report of two cases 61
Urinary incontinence in women. state of art and medical treatment 61
Advances in small molecule maintenance therapies for high-grade serous ovarian cancer 60
Epistaxis in Weekly Paclitaxel Regimen: Is it Really Related to Schedule? 60
Bmi is a key prognostic factor in stage iiic-iv ovarian cancer diagnosed prior 65 years old: a 10-year survival analysis 60
null 60
Long-term quality of life and sexual function after neoadjuvant chemotherapy and radical surgery for locally advanced cervical cancer 60
Modified gluteal fold advancement V-Y flap for vulvar reconstruction after surgery for vulvar malignancies 58
Management of morbidity associated with pancreatic resection during cytoreductive surgery for epithelial ovarian cancer: a systematic review 58
Evaluation of parametrial status in locally advanced cervical cancer patients after neoadjuvant chemotherapy: a prospective study on diagnostic accuracy of three-dimensional transvaginal ultrasound 58
The use of misoprostol and mifepristone in second trimester interruption of pregnancy. State of art 57
Combined vesicouterine rupture during second-trimester medical abortion for fetal abnormality after prior cesarean delivery: a case report 57
PEGYLATED LYPOSOMAL DOXORUBICIN IN PATIENTS AFFECTED BY ADVANCED OR RECURRENT CERVICAL CANCER 56
Laparoscopic surgery in treatment of Stage IIb cervical cancer after neoadjuvant chemotherapy. A case report and review of the literature 55
Hormone therapy in oophorectomized BRCA1/2 mutation carriers 55
Minimally Invasive Surgical Approach for Treatment of Isolated Endometrial Cancer Recurrence in an Ultra-Morbidly Obese Patient 55
Thinking twice before abandoning first-line chemotherapy in ovarian cancer: report of two cases and literature review. Passing from tri-weekly to weekly regimens 55
The role of 3D transvaginal ultrasound in the evaluation of response to chemotherapy in patients affected by locally advanced cervical cancer. 55
Optimizing the total laparoscopic hysterectomy procedure for benign uterine pathology 54
null 54
Defecation proctography and translabial ultrasound in the investigation of defecatory disorders 54
null 54
Simple extrafascial trachelectomy and pelvic bilateral lymphadenectomy in early stage cervical cancer 54
Immune checkpoint inhibitors: a promising choice for endometrial cancer patients? 54
Preoperative frailty assessment in patients undergoing gynecologic oncology surgery. A systematic review 54
Predictors of postoperative morbidity after cytoreduction for advanced ovarian cancer. Analysis and management of complications in upper abdominal surgery 54
Secondary analyses from a randomized clinical trial: age as the key prognostic factor in endometrial carcinoma 54
Fertility-sparing surgery for women with stage I cervical cancer of 4 cm or larger. A systematic review 53
The role of microbiota in female fertility and infertility 52
Texture analysis versus conventional MRI prognostic factors in predicting tumor response to neoadjuvant chemotherapy in patients with locally advanced cancer of the uterine cervix 52
Non-invasive treatment of vulvovaginal atrophy in menopause with CO2 laser 52
Totale 7.292
Categoria #
all - tutte 36.082
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.082


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020786 0 0 0 0 0 0 0 225 225 180 104 52
2020/2021827 61 110 66 53 42 24 50 61 70 80 111 99
2021/20221.568 30 67 125 45 197 114 48 166 149 108 208 311
2022/20232.035 374 411 101 229 217 179 90 112 156 25 88 53
2023/20241.428 67 144 40 163 169 182 33 178 19 173 108 152
2024/20251.521 103 194 219 182 298 216 210 99 0 0 0 0
Totale 10.564